Out-of-Stock – COVID-19 – Authorisations for the temporary import and distribution of human medicines – Update
Status as of 12.08.2020
In Ordinance 3 on Measures to Combat the Coronavirus (Covid-19 Ordinance 3, SR 818.101.24), the Federal Council issues provisions designed to ensure the supply of important medical goods. Based on Art. 22 para. 3 of this ordinance, Swissmedic can approve the import of essentially identical medicinal products as a short-term solution for any temporary non-availability of medicinal products.
The following table lists the temporary import and distribution licences granted by Swissmedic on the basis of the Covid-19 Ordinance. The products may only be distributed to hospitals. The allocation of the goods and information provided on their respective availability is generally the responsibility of the department at the Federal Office of Public Health responsible for procuring medical goods.
| Active substance |
Pharmaceutical form / Dosage |
Batch reference |
Distribution licensed until |
| Lopinavir / Ritonavir |
Film-coated tablets, 200 mg/tab. and 50 mg/tab.
Syrup, 400 mg/5 ml and 100 mg/5 ml |
1125683 / 1125601/ 1126558
6088208 / 6088549 |
31.12.2020 |
| Erythromycin |
Powder for solution for infusion, 1 g |
01124TB23 |
31.07.2020 |
| Hydroxychloroquine |
Lactab, 200 mg |
IYZ019 001- IYZ019 007 |
31.12.2020 |
| Atazanavir |
Capsules, 200 mg |
ABH6626 |
30.11.2020 |
| Propofol |
Emulsion for injection/infusion, 10 mg/ml |
V19A013A / V19A013B / V19A013C |
31.12.2020 |
| Budesonide / Formoterol |
Powder for inhalation, 100 µg/6 µg |
SLGV |
31.08.2020 |
| Rocuronium |
Solution for injection 50 mg/5 ml |
T007003 |
31.12.2020 |
| Propofol |
Emulsion for injection and infusion, 10 mg/ml |
10PC9969 / 16PB6740 |
31.12.2020 |
| Hydroxychloroquine |
Film-coated tablets, 200 mg |
JM2447 |
31.12.2020 |
| Lopinavir / Ritonavir |
Tablets, 200 mg/50 mg |
E200320 |
31.12.2020 |
| Sufentanil / Sufentanil citrate |
Solution for injection,
0.005 mg/ml and 0.05 mg/ml |
MU9A (0.005mg/ml
5 x 2ml)
JG9W (0.005mg/ml
10 x 10ml)
HG2B (0.05mg/ml
10 x 5ml) |
31.05.2020 |
| Solution for haemodialysis and haemofiltration |
Sodium 140 mmol/l
Potassium 4 mmol/l
Magnesium 0.75 mmol/l
Chloride 122 mmol/l
Hydrogen phosphate 1 mmol/l
Hydrogen carbonate 22 mmol/l/ 1000 ml |
19G0415
19K0610
|
30.06.2020 |
| Sufentanil / Sufentanil citrate |
Solution for injection,
0.005 mg/ml
5 x 10 ml |
Batch BG4 |
30.06.2020 |
| Midazolam |
Ampoules, 50 mg/10 ml |
F1038F08 / F1048F02 |
31.12.2020 |
| Posaconazole |
Gastro-resistant tablet, 100 mg |
T001796 and T001390 |
01.11.2020 |
| Propofol |
Ampoules, 50 mg/10 ml |
F1058F02 |
31.12.2020 |
| Rocuronium |
Solution for injection 50 mg/5 ml |
T012764 |
31.01.2021 |
| Budesonide / Formoterol |
Powder for inhalation, 100 µg/6 µg |
LATU |
31.08.2020 |
| Propofol |
Emulsion for infusion 2 % MCT |
16PD7549 |
31.12.2020 |
| Amoxicillin / Clavulanic acid |
2g/200 mg, powder for preparation of a solution for injection or infusion |
KP0957 |
31.08.2020 |
| Amoxicillin / Clavulanic acid |
2g/200 mg, powder for preparation of a solution for injection or infusion |
KS3426
KS3427 |
30.10.2020 |
Medicinal products imported by hospital pharmacists under their own responsibility according to Art. 22 para. 1 of the Covid-19 Ordinance 3 are not included in this list.
